MEDsan Covid-19 Rapid Antibody Test (IgM/IgG)
MEDsan COVID-19 IgM/IgG Rapid Test Hybrid is a solid phase immunochromatographic assay for the rapid, qualitative and differential detection of IgM and IgG antibodies against novel coronavirus SARS-CoV-2 infected cells in human whole blood, serum or plasma. This test provides only a preliminary test result. Therefore, any reactive specimen with the MEDsan COVID-19 IgM/IgG Rapid Test must be confirmed with alternative testing method(s) and clinical findings.
The MEDsan COVID-19 IgM/IgG Rapid Test Hybrid is a CE marked lateral flow immunochromatographic assay. The test uses anti-human IgM antibody (test line IgM), anti-human IgG (test line IgG) and goat anti-mouse IgG (control line C) immobilized on a nitrocellulose strip. The burgundy colored conjugate pad contains colloidal gold conjugated to recombinant COVID-19 antigens conjugated with colloid gold (COVID-19 conjugates) and mouse IgG-gold conjugates. When a specimen followed by assay buffer is added to the sample well, IgM &/or IgG antibodies if present, will bind to COVID-19 conjugates making antigen antibodies complex. This complex migrates through nitrocellulose membrane by capillary action. When the complex meets the line of the corresponding immobilized antibody (anti-human IgM &/or anti-human IgG) the complex is trapped forming a burgundy colored band which confirms a reactive test result. Absence of a colored band in the test region indicates a non- reactive test result.
Contents of the pack
Box of 25
BioeXsen SARS-CoV-2 RT PCR
MEDsan SARS-CoV-2 Antigene Rapid Test
MEDsan COVID-19 IgA/IgG Rapid Test
available as Hybrid and OMT (Oral mucosal transudate)